Alex Gorsky elected lead director of Neurotech’s board
Click Here to Manage Email Alerts
Key takeaways:
- Alex Gorsky has joined Neurotech as the board’s lead director.
- Gorsky is the former chairman and CEO of Johnson & Johnson.
Alex Gorsky, the former chairman and CEO of Johnson & Johnson, has been elected to Neurotech’s board as lead director, according to a press release.
Gorsky has served as a member of industry groups including the Business Roundtable and the Business Council and currently sits on the boards of Apple, IBM, JPMorgan Chase and the Travis Manion Foundation, as well as the Wharton School of the University of Pennsylvania Board of Advisors. Under his leadership, Johnson & Johnson grew to become the world’s largest diversified health care company, the release said.
Neurotech said it is working with the FDA to prepare a biologics license application for the NT-501 implant, which is designed to slow the progression of macular telangiectasia (MacTel) type 2 and other retinal-based diseases.
The encapsulated cell therapy platform demonstrated positive phase 3 safety and durability results as a long-term treatment for MacTel.
“I am delighted to welcome Alex to Neurotech’s board of directors,” Jim Mazzo, Neurotech’s executive chairman, said in the release. “As a visionary in patient-focused health care, his expertise and enthusiasm for innovative technology will greatly enrich Neurotech’s mission to revolutionize treatments for various ocular diseases using our encapsulated cell therapy.”
Read more about
Click Here to Manage Email Alerts